Paraoxonase 1 polymorphisms and risk of myocardial infarction in women and men

Circulation Journal

Volumn 73, Issue 7, 2009, Pages 1302-1307

  Mukamal, Kenneth J ^a,b   Pai, Jennifer K ^a   Jensen, Majken K ^a   Rimm, Eric B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Alcohol; Epidemiology; Genotype; Lipids; Myocardial infarction

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; MONOUNSATURATED FATTY ACID;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIET; FAT INTAKE; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MALE; PARALLEL DESIGN; PROSPECTIVE STUDY; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADULT; ALCOHOL DRINKING; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; UNITED STATES;

EID: 68149178330     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0912     Document Type: Article

References (55)

1. Mackness MI, Mackness B, Durrington PN. Paraoxonase and coronary heart disease. Atheroscler Suppl 2002; 3: 49-55. (Pubitemid 38234486)
2. Zintzaras E, Hadjigeorgiou GM. Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: A meta-analysis. J Hum Genet 2004; 49: 474-481. (Pubitemid 39314366)
3. Wheeler JG, Keavney BD, Watkins H, Collins R, Danesh J. Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: Meta-analysis of 43 studies. Lancet 2004; 363: 689-695. (Pubitemid 38296555)
4. Lawlor DA, Day IN, Gaunt TR, Hinks LJ, Briggs PJ, Kiessling M, et al. The association of the PON1 Q192R polymorphism with coronary heart disease: Findings from the British Women's Heart and Health cohort study and a meta-analysis. BMC Genet 2004; 5: 17.
5. Morray B, Goldenberg I, Moss AJ, Zareba W, Ryan D, McNitt S, et al. Polymorphisms in the paraoxonase and endothelial nitric oxide synthase genes and the risk of early-onset myocardial infarction. Am J Cardiol 2007; 99: 1100-1115. (Pubitemid 46560456)
6. Balcerzyk A, Zak I, Krauze J. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease. Arch Med Res 2007; 38: 545-550. (Pubitemid 46873816)
7. Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 2008; 299: 1265-1276.
8. Ellison RC, Zhang Y, Qureshi MM, Knox S, Arnett DK, Province MA. Lifestyle determinants of high-density lipoprotein cholesterol: The National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J 2004; 147: 529-535.
9. Kim SM, Han JH, Park HS. Prevalence of low HDL-cholesterol levels and associated factors among Koreans. Circ J 2006; 70: 820-826. (Pubitemid 43979116)
10. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: Meta-analysis of effects on lipids and haemostatic factors. BMJ 1999; 319: 1523-1528.
11. Rao MN Marmillot P, Gong M, Palmer DA, Seeff LB, Strader DB, et al. Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans. Metabolism 2003; 52: 1287-1294. (Pubitemid 37351096)
12. Sierksma A, van der Gaag MS, van Tol A, James RW, Hendriks HF. Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers. Alcohol Clin Exp Res 2002; 26: 1430-1435.
13. van der Gaag MS, van Tol A, Scheek LM, James RW, Urgert R, Schaafsma G, et al. Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis 1999; 147: 405-410. (Pubitemid 29512273)
14. Wang X, Huang J, Fan Z, Su S, Zhao J, Shen Y, et al. Genetic and environmental factors associated with plasma paraoxonase activity in healthy Chinese. Int J Mol Med 2004; 13: 445-450.
15. Volcik K, Ballantyne CM, Pownall HJ, Sharrett AR, Boerwinkle E. Interaction effects of high-density lipoprotein metabolism gene variation and alcohol consumption on coronary heart disease risk: The atherosclerosis risk in communities study. J Stud Alcohol Drugs 2007; 68: 485-492. (Pubitemid 47092975)
16. Blum S, Aviram M, Ben-Amotz A, Levy Y. Effect of a Mediterranean meal on postprandial carotenoids, paraoxonase activity and C-reactive protein levels. Ann Nutr Metab 2006; 50: 20-24. (Pubitemid 43097639)
17. Wallace AJ, Sutherland WH, Mann JI, Williams SM. The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes. Eur J Clin Nutr 2001; 55: 95-958.
18. Cherki M, Derouiche A, Drissi A, El Messal M, Bamou Y, Idrissi-Ouadghiri A, et al. Consumption of argan oil may have an antiatherogenic effect by improving paraoxonase activities and antioxidant status: Intervention study in healthy men. Nutr Metab Cardiovasc Dis 2005; 15: 352-360. (Pubitemid 41578780)
19. Tomas M, Senti M, Elosua R, Vila J, Sala J, Masia R, et al. Interaction between the Gin-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity. Eur J Pharmacol 2001; 432: 121-128. (Pubitemid 34003591)
20. Kudchodkar BJ, Lacko AG, Dory L, Fungwe TV. Dietary fat modulates serum paraoxonase 1 activity in rats. J Nutr 2000; 130: 2427-2433. (Pubitemid 30737854)
21. Ferre N, Camps J, Fernandez-Ballart J, Arija V, Murphy MM, Ceruelo S, et al. Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. Clin Chem 2003; 49: 1491-1497. (Pubitemid 37011737)
22. Vincent-Viry M, Sass C, Bastien S, Aguillon D, Siest G, Visvikis S. PON1-192 phenotype and genotype assessments in 9,8 subjects of the Stanislas cohort study. Clin Chem Lab Med 2003; 41: 535-540. (Pubitemid 36592121)
23. Nishio E, Watanabe Y. Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme's free thiols. Biochem Biophys Res Commun 1997; 236: 289-293. (Pubitemid 27373286)
24. Belanger CF, Hennekens CH, Rosner B, Speizer FE. The Nurses' Health Study. Am J Nurs 1978; 78: 1039-1040.
25. Colditz GA. The Nurses' Health Study: Findings during 10 years of follow-up of a cohort of US women. Curr Probl Obstet Gynecol Fertil 1990; 13: 129-174.
26. Colditz GA. The Nurses' Health Study: A cohort of US women followed since 1976. J Am Med Womens Assoc 1995; 50: 40-44.
27. Rimm EB, Stampfer MJ, Colditz GA, Giovannucci E, Willett WC. Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study. Am J Epidemiol 1990; 131: 1068-1071. (Pubitemid 20178628)
28. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991; 338: 464-468.
29. Pischon T, Pai JK, Manson JE, Hu FB, Rexrode KM, Hunter D, et al. Peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and risk of coronary heart disease in US men and women. Arterioscler Thromb Vasc Biol 2005; 25: 1654-1658. (Pubitemid 41098936)
30. Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA Jr, Stampfer MJ, Willett WC, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003; 348: 109-118.
31. Giovannucci E, Colditz G, Stampfer MJ, Rimm EB, Litin L, Sampson L, et al. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 1991; 133: 810-817.
32. Hunter DJ, Rimm EB, Sacks FM, Stampfer MJ, Colditz GA, Litin LB, et al. Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol 1992; 135: 418-427.
33. Prentice RL, Breslow NE. Retrospective studies and failure time models. Biometrika 1978; 65: 153-158.
34. Mukamal KJ, Jensen MK, Gronbaek M, Stampfer MJ, Manson JE, Pischon T, et al. Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation 2005; 112: 1406-1413. (Pubitemid 41291765)
35. Sarandol E, Serdar Z, Dirican M, Safak O. Effects of red wine consumption on serum paraoxonase/arylesterase activities and on lipoprotein oxidizability in healthy-men. J Nutr Biochem 2003; 14: 507-512. (Pubitemid 37162649)
36. Roest M, van Himbergen TM, Barendrecht AB, Peeters PH, van der Schouw YT, Voorbij HA. Genetic and environmental determinants of the PON-1 phenotype. Eur J Clin Invest 2007; 37: 187-196. (Pubitemid 46310581)
37. Gaidukov L, Rosenblat M, Aviram M, Tawfik DS. The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux. J Lipid Res 2006; 47: 2492-2502. (Pubitemid 44936111)
38. Shimizu M, Kanazawa K, Hirata K, Ishida T, Hiraoka E, Matsuda Y, et al. Endothelial lipase gene polymorphism is associated with acute myocardial infarction, independently of high-density lipoprotein-cholesterol levels. Circ J 2007; 7: 842-846. (Pubitemid 46833920)
39. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br J Pharmacol 1997; 122: 265-268. (Pubitemid 27397197)
40. Baum L, Ng HK, Woo KS, Tomlinson B, Rainer TH, Chen X, et al. Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk. Clin Biochem 2006; 39: 191-195.
41. 4,. Li J, Wang X, Huo Y, Niu T, Chen C, Zhu G, et al. PON1 polymorphism, diabetes mellitus, obesity, and risk of myocardial infarction: Modifying effect of diabetes mellitus and obesity on the association between PON1 polymorphism and myocardial infarction. Genet Med 2005; 7: 58-63. (Pubitemid 40111133)
42. Burdon KP, Langefeld CD, Beck SR, Wagenknecht LE, Carr JJ, Freedman BI, et al. Association of genes of lipid metabolism with measures of subclinical cardiovascular disease in the Diabetes Heart Study. J Med Genet 2005; 42: 720-724. (Pubitemid 41306063)
43. Rodriguez-Esparragon F, Rodriguez-Perez JC, Hernandez-Trujillo Y, Macias-Reyes A, Medina A, Caballero A, et al. Allelic variants of the human scavenger receptor class B type 1 and paraoxonase 1 on coronary heart disease: Genotype-phenotype correlations. Arterioscler Thromb Vasc Biol 2005; 25: 854-860. (Pubitemid 40463881)
44. Su SY, Chen JH, Huang JF, Wang XL, Zhao JG, Shen Y, et al. Paraoxonase gene cluster variations associated with coronary heart disease in Chinese Han women. Chin Med J (Engl) 2005; 118: 1167-1174. (Pubitemid 41051616)
45. Rios DL, D'Onofrio LO, Cerqueira CC, Bonfim-Silva R, Carvalho HG, Santos-Filho A, et al. Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: Evidence for gender interaction among Brazilians. Clin Chem Lab Med 2007; 45: 874-878. (Pubitemid 47041881)
46. Mashiba J, Koike G, Kamiunten H, Ikeda M, Sunagawa K. Vasospastic angina and microvascular angina are differentially influenced by PON1 A632G polymorphism in the Japanese. Circ J 2005; 69: 1466-1471. (Pubitemid 41743960)
47. Mackness B, Durrington P, McElduff P, Yarnell J, Azam N, Watt M, et al. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 2003; 107: 2775-2779. (Pubitemid 36705985)
48. van Himbergen TM, van der Schouw YT, Voorbij HA, van Tits LJ, Stalenhoef AF, Peeters PH, et al. Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women. Atherosclerosis 2008; 199: 408-414.
49. Heistad DD, Wakisaka Y, Miller J, Chu Y, Pena-Silva R. Novel aspects of oxidative stress in cardiovascular diseases. Circ J 2009; 73: 201-207.
50. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 2009; 73: 411-418.
51. James RW, Leviev I, Righetti A. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. Circulation 2000; 101: 2252-2257. (Pubitemid 30317126)
52. Erguder IB, Erguder T, Ozkan C, Bozkurt N, Soylu K, Devrim E, et al. Short-term effects of smoking cessation on blood antioxidant parameters and paraoxonase activity in healthy asymptomatic long-term cigarette smokers. Inhal Toxicol 2006; 18: 575-579. (Pubitemid 43977253)
53. Ferre N, Camps J, Fernandez-Ballart J, Arija V, Murphy MM, Marsillach J, et al. Longitudinal changes in serum paraoxonase-1 activity throughout normal pregnancy. Clin Chem Lab Med 2006; 44: 880-882. (Pubitemid 43911564)
54. Kumru S, Aydin S, Gursu MF, Ozcan Z. Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women. Eur J Obstet Gynecol Reprod Biol 2004; 114: 177-181. (Pubitemid 38622079)
55. Topcuoglu A, Uzun H, Aydin S, Kahraman N, Vehid S, Zeybek G, et al. The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women. Tohoku J Exp Med 2005; 205: 79-86. (Pubitemid 40260057)